Arcadia Biosciences, Inc. (RKDA) stock: key figures, P/E, revenue and dividend
Energy · United States · ISIN US0390143032
Arcadia Biosciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 4.86 m USD |
| Gross profit | 1.76 m USD |
| Operating income | -2.50 m USD |
| EBIT | -2.33 m USD |
| Net income | -2.34 m USD |
| Diluted EPS – continuing operations | -1.71 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
More stocks
- Agape ATP Corp (ATPC)
- IT TECH PACKAGING, INC. (ITP)
- Zeo Energy Corp. (ZEO)
- BIOTRICITY INC. (BTCY)
- BMP AI Technologies, Inc. (BMPA)
- QUEST PATENT RESEARCH CORP (QPRC)
- LogicMark, Inc. (LGMK)
- CLOUDASTRUCTURE, INC. (CSAI)
- Silexion Therapeutics Corp (SLXN)
- Nuvve Holding Corp. (NVVE)
- Appsoft Technologies, Inc. (ASFT)
- GeoVax Labs, Inc. (GOVX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.